Argenx
ARGX
#481
Rank
NZ$84.19 B
Marketcap
NZ$1,361
Share price
-1.39%
Change (1 day)
18.65%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company